MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1

A simple technique for quantitation of low levels of DNA damage in individual cells

Narendra P. Singh, Michael T. McCoy, Raymond R. Tice et al. · Experimental Cell Research · 1988 · 10.8K citations · Full text

Pharmacy, Cell Biology, Molecular Biology +10

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

Ana-Maria Florea, Dietrich Büsselberg · Cancers · 2011 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17

MicroRNA Expression Profiling in Human Ovarian Cancer: <i>miR-214</i> Induces Cell Survival and Cisplatin Resistance by Targeting <i>PTEN</i>

Hua Yang, William Kong, Lili He et al. · Cancer Research · 2008 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +17

MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1

Tyler E. Miller, Kalpana Ghoshal, Bhuvaneswari Ramaswamy et al. · Journal of Biological Chemistry · 2008 · 750 citations · Full text

Medicine, Molecular Biology, Oncology +17